ONTOLOGY REPORT - ANNOTATIONS
| Term: | erythromycin estolate |
|
| Accession: | CHEBI:4846
|
browse the term
|
| Definition: | An erythromycin derivative that has formula C40H71NO14.C12H26O4S. |
| Synonyms: | exact_synonym: | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-6-[3,4,6-trideoxy-3-(dimethylamino)-2-O-propanoyl-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione dodecyl hydrogen sulfate |
| | related_synonym: | C40H71NO14.C12H26O4S; CCCCCCCCCCCCOS(O)(=O)=O.CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2OC(=O)CC)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O; Eriscel; Eritroger; Eromycin; Erythromycin estorate; Estomicina; Ilosone; InChI=1S/C40H71NO14.C12H26O4S/c1-15-27-40(11,48)33(44)22(5)30(43)20(3)18-38(9,47)35(55-37-32(53-28(42)16-2)26(41(12)13)17-21(4)50-37)23(6)31(24(7)36(46)52-27)54-29-19-39(10,49-14)34(45)25(8)51-29;1-2-3-4-5-6-7-8-9-10-11-12-16-17(13,14)15/h20-27,29,31-35,37,44-45,47-48H,15-19H2,1-14H3;2-12H2,1H3,(H,13,14,15)/t20-,21-,22+,23+,24-,25+,26+,27-,29+,31+,32-,33-,34+,35-,37+,38-,39-,40-;/m1./s1; InChIKey=AWMFUEJKWXESNL-JZBHMOKNSA-N; Lauromicina; Marcoeritrex; Neo-erycinum; PELS; Roxomicina; Stellamicina; erythromycin 2'-propionate dodecyl sulfate (salt); erythromycin propionate, compound with dodecyl sulfate; lauryl sulfate propionyl erythromycin ester; monopropionylerythromycin laurylsulfate; propionic acid, 2'-ester with erythromycin, dodecyl sulfate; propionylerythromycin lauryl sulfate |
| | xref_casrn: | 3521-62-8 |
| | xref: | Beilstein:3897327 "Beilstein Registry Number"; ChEMBL:1549150 "ChEMBL COMPOUND"; ChemIDplus:3521-62-8 "CAS Registry Number"; KEGG COMPOUND:3521-62-8 "CAS Registry Number"; KEGG COMPOUND:C08031 "KEGG COMPOUND"; KEGG DRUG:D00851 "KEGG DRUG"; LIPID MAPS:LMPK04000015 "LIPID MAPS instance" |
| | xref_mesh: | MESH:D004918 |
| | xref: | Patent:US3000874 "Patent" |
|
|
erythromycin estolate
|
| G |
ABCB1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
|
increases expression |
ISO |
7 |
87,133,179 |
87,342,639 |
RGD:6480464 |
CTD |
| G |
ABCB11 |
ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
|
decreases activity |
EXP |
2 |
169,779,449 |
169,887,833 |
RGD:6480464 |
CTD |
| G |
ABCB11 |
ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
|
decreases expression |
ISO |
2 |
169,779,449 |
169,887,833 |
RGD:6480464 |
CTD |
| G |
ABCC3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
|
increases expression |
ISO |
17 |
48,712,218 |
48,769,063 |
RGD:6480464 |
CTD |
| G |
ACADM |
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
decreases expression |
ISO |
1 |
76,190,043 |
76,229,355 |
RGD:6480464 |
CTD |
| G |
ACLY |
ATP citrate lyase |
|
decreases expression |
ISO |
17 |
40,023,179 |
40,075,272 |
RGD:6480464 |
CTD |
| G |
ACSL1 |
acyl-CoA synthetase long-chain family member 1 |
|
decreases expression |
ISO |
4 |
185,676,749 |
185,747,215 |
RGD:6480464 |
CTD |
| G |
ALDH3A2 |
aldehyde dehydrogenase 3 family, member A2 |
|
decreases expression |
ISO |
17 |
19,552,064 |
19,580,908 |
RGD:6480464 |
CTD |
| G |
APEX1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
decreases expression |
ISO |
14 |
20,923,290 |
20,925,931 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
decreases expression |
ISO |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
ISO |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BTG2 |
BTG family, member 2 |
|
increases expression |
ISO |
1 |
203,274,664 |
203,278,730 |
RGD:6480464 |
CTD |
| G |
CALU |
calumenin |
|
increases expression |
ISO |
7 |
128,379,346 |
128,413,477 |
RGD:6480464 |
CTD |
| G |
CALU |
calumenin |
|
increases expression |
ISO |
7 |
128,379,346 |
128,413,477 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
decreases expression |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CEACAM1 |
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
|
decreases expression |
ISO |
19 |
43,011,458 |
43,032,661 |
RGD:6480464 |
CTD |
| G |
CTSL1 |
cathepsin L1 |
|
increases expression |
ISO |
9 |
90,340,974 |
90,346,384 |
RGD:6480464 |
CTD |
| G |
CYB5R3 |
cytochrome b5 reductase 3 |
|
decreases expression |
ISO |
22 |
43,013,846 |
43,045,405 |
RGD:6480464 |
CTD |
| G |
CYP2D6 |
cytochrome P450, family 2, subfamily D, polypeptide 6 |
|
decreases expression |
ISO |
22 |
42,522,501 |
42,526,883 |
RGD:6480464 |
CTD |
| G |
DDIT3 |
DNA-damage-inducible transcript 3 |
|
increases expression |
ISO |
12 |
57,910,371 |
57,914,300 |
RGD:6480464 |
CTD |
| G |
FABP1 |
fatty acid binding protein 1, liver |
|
increases expression |
ISO |
2 |
88,422,501 |
88,427,650 |
RGD:6480464 |
CTD |
| G |
FADS1 |
fatty acid desaturase 1 |
|
decreases expression |
ISO |
11 |
61,567,097 |
61,584,529 |
RGD:6480464 |
CTD |
| G |
FASN |
fatty acid synthase |
|
decreases expression |
ISO |
17 |
80,036,214 |
80,056,106 |
RGD:6480464 |
CTD |
| G |
FGA |
fibrinogen alpha chain |
|
increases expression |
ISO |
4 |
155,504,280 |
155,511,897 |
RGD:6480464 |
CTD |
| G |
FGB |
fibrinogen beta chain |
|
increases expression |
ISO |
4 |
155,484,132 |
155,493,915 |
RGD:6480464 |
CTD |
| G |
FMO1 |
flavin containing monooxygenase 1 |
|
decreases expression |
ISO |
1 |
171,217,663 |
171,255,113 |
RGD:6480464 |
CTD |
| G |
GADD45A |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
ISO |
1 |
68,150,860 |
68,154,021 |
RGD:6480464 |
CTD |
| G |
GCK |
glucokinase (hexokinase 4) |
|
decreases expression |
ISO |
7 |
44,183,870 |
44,229,022 |
RGD:6480464 |
CTD |
| G |
GPX1 |
glutathione peroxidase 1 |
|
decreases expression |
ISO |
3 |
49,394,609 |
49,395,791 |
RGD:6480464 |
CTD |
| G |
GSTM3 |
glutathione S-transferase mu 3 (brain) |
|
decreases expression |
ISO |
1 |
110,276,554 |
110,283,660 |
RGD:6480464 |
CTD |
| G |
HIBADH |
3-hydroxyisobutyrate dehydrogenase |
|
decreases expression |
ISO |
7 |
27,565,059 |
27,702,620 |
RGD:6480464 |
CTD |
| G |
IGFBP1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
ISO |
7 |
45,927,959 |
45,933,267 |
RGD:6480464 |
CTD |
| G |
KRT18 |
keratin 18 |
|
increases expression |
ISO |
12 |
53,342,655 |
53,346,685 |
RGD:6480464 |
CTD |
| G |
LBP |
lipopolysaccharide binding protein |
|
increases expression |
ISO |
20 |
36,974,814 |
37,005,653 |
RGD:6480464 |
CTD |
| G |
LGALS3 |
lectin, galactoside-binding, soluble, 3 |
|
increases expression |
ISO |
14 |
55,595,935 |
55,612,148 |
RGD:6480464 |
CTD |
| G |
LIPC |
lipase, hepatic |
|
decreases expression |
ISO |
15 |
58,724,175 |
58,861,073 |
RGD:6480464 |
CTD |
| G |
LPL |
lipoprotein lipase |
|
increases expression |
ISO |
8 |
19,796,582 |
19,824,770 |
RGD:6480464 |
CTD |
| G |
MAOB |
monoamine oxidase B |
|
decreases expression |
ISO |
X |
43,625,857 |
43,741,721 |
RGD:6480464 |
CTD |
| G |
MYC |
v-myc myelocytomatosis viral oncogene homolog (avian) |
|
increases expression |
ISO |
8 |
128,748,315 |
128,753,680 |
RGD:6480464 |
CTD |
| G |
NFKBIB |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
|
decreases expression |
ISO |
19 |
39,390,340 |
39,399,534 |
RGD:6480464 |
CTD |
| G |
OTC |
ornithine carbamoyltransferase |
|
decreases expression |
ISO |
X |
38,211,736 |
38,280,703 |
RGD:6480464 |
CTD |
| G |
PKLR |
pyruvate kinase, liver and RBC |
|
decreases expression |
ISO |
1 |
155,259,084 |
155,271,225 |
RGD:6480464 |
CTD |
| G |
PYGL |
phosphorylase, glycogen, liver |
|
decreases expression |
ISO |
14 |
51,371,935 |
51,411,248 |
RGD:6480464 |
CTD |
| G |
S100A8 |
S100 calcium binding protein A8 |
|
increases expression |
ISO |
1 |
153,362,508 |
153,363,664 |
RGD:6480464 |
CTD |
| G |
S100A9 |
S100 calcium binding protein A9 |
|
increases expression |
ISO |
1 |
153,330,330 |
153,333,503 |
RGD:6480464 |
CTD |
| G |
SLCO1B3 |
solute carrier organic anion transporter family, member 1B3 |
|
decreases expression |
ISO |
12 |
20,963,638 |
21,069,845 |
RGD:6480464 |
CTD |
| G |
SPIN2B |
spindlin family, member 2B |
|
decreases expression |
ISO |
X |
57,146,115 |
57,147,979 |
RGD:6480464 |
CTD |
| G |
SREBF1 |
sterol regulatory element binding transcription factor 1 |
|
decreases expression |
ISO |
17 |
17,714,663 |
17,740,325 |
RGD:6480464 |
CTD |
| G |
STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
increases expression |
ISO |
17 |
40,465,343 |
40,540,513 |
RGD:6480464 |
CTD |
| G |
THRSP |
thyroid hormone responsive |
|
decreases expression |
ISO |
11 |
77,774,907 |
77,779,403 |
RGD:6480464 |
CTD |
| G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
ISO |
X |
47,441,690 |
47,446,190 |
RGD:6480464 |
CTD |
| G |
TNFRSF1A |
tumor necrosis factor receptor superfamily, member 1A |
|
increases expression |
ISO |
12 |
6,437,923 |
6,451,283 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
decreases expression |
ISO |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TTR |
transthyretin |
|
decreases expression |
ISO |
18 |
29,171,730 |
29,178,987 |
RGD:6480464 |
CTD |
| G |
TXNRD1 |
thioredoxin reductase 1 |
|
decreases expression |
ISO |
12 |
104,609,557 |
104,744,085 |
RGD:6480464 |
CTD |
Term paths to the root
|